<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-vaccines-08-00224">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ling</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Xun</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications</article-title>
  <source>medRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.2139/ssrn.3566211</pub-id>
 </element-citation>
</ref>
